Author

Kate Plas

University of Cincinnati

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Andrea LagansoniD· 1 shared Andrew J. CarrolliD· 1 shared Andrew R. StiffiD· 1 shared Ann‐Kathrin EisfeldiD· 1 shared Bayard L. Powell· 1 shared Christopher James WalkeriD· 1 shared Courtney Denton DinardoiD· 1 shared Darren LeeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrea LagansonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Prognostic and Therapeutic Implications of BRAF Mutations in Acute Myeloid Leukemia

Darren Lee, Yazan Abu-Shihab, Kate Plas, Deedra Nicolet, Krzysztof Mrózek, Mark J. Routbort, Keyur Pravinchandra Patel, Christopher James Walker, Jill L. Buss, Andrew R. Stiff, Andrea Laganson, Courtney Denton Dinardo, Naval Guastad Daver, Tapan Mahendra Kadia, Farhad Ravandi, , Linde A. Miles

This study identifies BRAF mutations in AML, showing poor outcomes and unique co-mutation patterns, suggesting potential targeted therapies.

Leukemia · Jun 15, 2026Peer-reviewedCancer Biology